AI-generated summary
This double-blind randomized controlled trial in 44 males with androgenic alopecia compared a 655 nm red light device with a placebo device that emitted incandescent red light. The authors report that 41 patients completed the study, with no adverse events or side effects reported, and that the active group showed a greater percent increase in hair counts than placebo at 16 weeks.
- Participants
- 44
- Who or what was studied
- Males aged 18 to 48 with androgenic alopecia (Fitzpatrick I-IV, Hamilton-Norwood IIa-V)
- Wavelengths
- 655 nm
- Limits stated in the abstract
- The abstract reports a single 16-week trial in a small sample, and the placebo result shifted when one outlier was removed, so the finding depends on the analysis chosen.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 655 nm
- Power
- 5 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Light-emitting diode, Low-level laser therapy, Randomized controlled trial, Androgenetic alopecia, Irradiance. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.